Skip to main content
Skip to navigation

Drug Companies Face Stricter Clinical Trial Regulation Worldwide

By Joe Mont2014-02-11T00:00:00

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

Related articles

Article
Crackdown on late payments could lead to U.K. companies facing million-pound fines

2025-08-07T15:59:00Z By Ruth Prickett

Late payers will soon face much larger fines in the U.K. in what is promised to be the “toughest crackdown on late payments in a generation.” The scheme is intended to save the 38 businesses a day that go bust because of poor payment practices.
Basic Page
NJ manufacturer fined by CPSC for failing to report deadly defect in its air conditioners

2025-08-06T20:18:00Z By Aly McDevitt

A delayed product hazard report cost one company criminal and civil penalties—and a mother her life. This case shows why timely reporting and executive accountability are non-negotiable for compliance teams.
News Brief
CFPB could run out of money by fall, report says

2025-08-06T14:00:00Z By Oscar Gonzalez

The Trump administration declawed the Consumer Financial Protection Bureau from the very beginning of his second term. It now appears the agency might be running out of money.